Xeris Biopharma scores FDA approval for endogenous Cushing’s syndrome drug Recorlev December 30, 2021 Auto Bot News 0 Xeris Biopharma scores FDA approval for endogenous Cushing’s syndrome drug Recorlev esagonowsky Thu, 12/30/2021 – 17:26
